Calcium Binding Is Required for Calmodulin Function in Aspergillus nidulans

Por Joseph, James D., Means, Anthony R.
Publicado em 2002

Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists

Por Joseph, James D., Wittmann, Bryan M., Dwyer, Mary A., Cui, Huaxia, Dye, Delita A., McDonnell, Donald P., Norris, John D.
Publicado em 2009

Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1

Por Doughty-Shenton, Dahlia, Joseph, James D., Zhang, Ji, Pagliarini, David J., Kim, Youngjun, Lu, Danhong, Dixon, Jack E., Casey, Patrick J.
Publicado em 2010

The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens

Por Norris, John D., Chang, Ching-Yi, Wittmann, Bryan M., Stein, Rebecca, Cui, Huaxia, Fan, Daju, Joseph, James D., McDonnell, Donald P.
Publicado em 2009

Induction of Krüppel-Like Factor 5 Expression by Androgens Results in Increased CXCR4-Dependent Migration of Prostate Cancer Cells in Vitro

Por Frigo, Daniel E., Sherk, Andrea B., Wittmann, Bryan M., Norris, John D., Wang, Qianben, Joseph, James D., Toner, Aidan P., Brown, Myles, McDonnell, Donald P.
Publicado em 2009

An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy

Por Orr, Christopher R., Montie, Heather L., Liu, Yuhong, Bolzoni, Elena, Jenkins, Shannon C., Wilson, Elizabeth M., Joseph, James D., McDonnell, Donald P., Merry, Diane E.
Publicado em 2010

Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927

Por Kahraman, Mehmet, Govek, Steven P., Nagasawa, Johnny Y., Lai, Andiliy, Bonnefous, Celine, Douglas, Karensa, Sensintaffar, John, Liu, Nhin, Lee, KyoungJin, Aparicio, Anna, Kaufman, Josh, Qian, Jing, Shao, Gang, Prudente, Rene, Joseph, James D., Darimont, Beatrice, Brigham, Daniel, Heyman, Richard, Rix, Peter J., Hager, Jeffrey H., Smith, Nicholas D.
Publicado no ACS Med Chem Lett (2018)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Por Joseph, James D, Darimont, Beatrice, Zhou, Wei, Arrazate, Alfonso, Young, Amy, Ingalla, Ellen, Walter, Kimberly, Blake, Robert A, Nonomiya, Jim, Guan, Zhengyu, Kategaya, Lorna, Govek, Steven P, Lai, Andiliy G, Kahraman, Mehmet, Brigham, Dan, Sensintaffar, John, Lu, Nhin, Shao, Gang, Qian, Jing, Grillot, Kate, Moon, Michael, Prudente, Rene, Bischoff, Eric, Lee, Kyoung-Jin, Bonnefous, Celine, Douglas, Karensa L, Julien, Jackaline D, Nagasawa, Johnny Y, Aparicio, Anna, Kaufman, Josh, Haley, Benjamin, Giltnane, Jennifer M, Wertz, Ingrid E, Lackner, Mark R, Nannini, Michelle A, Sampath, Deepak, Schwarz, Luis, Manning, Henry Charles, Tantawy, Mohammed Noor, Arteaga, Carlos L, Heyman, Richard A, Rix, Peter J, Friedman, Lori, Smith, Nicholas D, Metcalfe, Ciara, Hager, Jeffrey H
Publicado no eLife (2016)

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Por Joseph, James D, Darimont, Beatrice, Zhou, Wei, Arrazate, Alfonso, Young, Amy, Ingalla, Ellen, Walter, Kimberly, Blake, Robert A, Nonomiya, Jim, Guan, Zhengyu, Kategaya, Lorna, Govek, Steven P, Lai, Andiliy G, Kahraman, Mehmet, Brigham, Dan, Sensintaffar, John, Lu, Nhin, Shao, Gang, Qian, Jing, Grillot, Kate, Moon, Michael, Prudente, Rene, Bischoff, Eric, Lee, Kyoung-Jin, Bonnefous, Celine, Douglas, Karensa L, Julien, Jackaline D, Nagasawa, Johnny Y, Aparicio, Anna, Kaufman, Josh, Haley, Benjamin, Giltnane, Jennifer M, Wertz, Ingrid E, Lackner, Mark R, Nannini, Michelle A, Sampath, Deepak, Schwarz, Luis, Manning, Henry Charles, Tantawy, Mohammed Noor, Arteaga, Carlos L, Heyman, Richard A, Rix, Peter J, Friedman, Lori, Smith, Nicholas D, Metcalfe, Ciara, Hager, Jeffrey H
Publicado no eLife (2019)